“CaNCURE presented me with so many opportunities to explore the world of medicine, both inside and outside of the lab. I am eternally grateful for the connections I have made through CaNCURE at DFCI. In fact, I consulted both my day-today mentor and my PI when deciding between offers for my second co-op cycle.”
CaNCURE was created to provide Northeastern University undergrads with experiential training in cancer nanomedicine. Over 50 trainees have already completed the program.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research lab. This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school. 58% of alumni are currently performing cancer research.
Hear from our Alumni:
Targeted Delivery of Liposomes using PARP Inhibitors to Treat Non-Small Cell Lung Cancer
Health Sciences, '21
Analyzing metastasis through targeted miRNA nanotherapy in aggressive breast cancer
Health Science, '19
Molecular Analysis of Plasma Vesicles for Early Pancreatic Cancer Detection
Wilfred Ngwa, Ph.D.
Assistant Professor of Radiation Oncology,
My work integrates research, clinical service, and teaching in Radiation Oncology, with current focus on developing smart biomaterials (Tiny drones to Target cancer) designed to boost local and metastatic tumor cell kill with minimal collateral damage or side effects.
Rajiv Gupta, M.D., Ph.D.
Assistant Radiologist, MGH
Our lab is developing a prototype CT system, based on X-ray phases, which we expect to enable the visualization of normal and cancerous soft tissues in unprecedented detail. Students will parallel this effort by aiding in the development and optimization of tumor-targeted nanoparticles as CT contrast agents.
Cell and Molecular Biology, '21
The Nano-plasmonic Exosome (nPLEX) Assay for Pancreatic Ductal Adenocarcinoma Diagnosis and Prognosis
Behavioral Neuroscience, '19
Characterization of Nano-Dinaciclib in Combination with Nano-Talazoparib for the Treatment of Breast Cancer
Chemical Eng / Biochemistry, '21
Creating Animal Models of High-grade Serous Ovarian Cancer Cells